Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sunwels CoTSE:9229 +1.74%59 EBITDA Margin % is 40.00% as of Mar. 2026, which is 311% above its 10-year median of 9.73. GuruFocus rates TSE:9229 with a GF Score™ of 59/100 and a GF Value™ of 円1,185.01 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 665 Healthcare Providers & Services companies, Sunwels Co ranks worse than 61.35% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Sunwels Co's EBITDA for the
three
months ended in Mar. 2026 was 円2,961 Mil. Sunwels Co's Revenue for the
three
months ended in Mar. 2026 was 円7,402 Mil. Therefore, Sunwels Co's EBITDA margin for the quarter that ended in Mar. 2026 was 40.00%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Sunwels Co EBITDA Margin % Related Terms
Sunwels Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Sunwels Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:9229 vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Sunwels Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sunwels Co EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sunwels Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Sunwels Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sunwels Co (TSE:9229) has a EBITDA Margin % of 40.00% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Sunwels Co and its competitors. This is 311% above median its historical median of 9.73. Over the past decade, Sunwels Co's EBITDA Margin % has ranged from 6.69 to 15.69. According to the industry distribution chart, Sunwels Co ranks #408 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 61.4%.
Is Sunwels Co's EBITDA Margin % too high?
Sunwels Co's current EBITDA Margin % of 40.00% is 311% above median its 10-year median of 9.73. Over the past 10 years, this metric has ranged from a low of 6.69 to a high of 15.69. The Healthcare Providers & Services industry median EBITDA Margin % is 10.24. Sunwels Co's value of 40.00% is 290.6% above this industry median. Based on the distribution chart, Sunwels Co ranks #408 out of 665 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Sunwels Co has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sunwels Co's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Sunwels Co ranks #408 out of 665 companies for EBITDA Margin %. This places Sunwels Co in the lower half of its industry. The industry median EBITDA Margin % is 10.24. Sunwels Co's value of 40.00% is 290.6% above this benchmark. Historically, Sunwels Co's own EBITDA Margin % has ranged from 6.69 to 15.69 over the past decade. While the company's 10-year median is 9.73 vs. the industry median of 10.24, Sunwels Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sunwels Co's current EBITDA Margin % of 40.00% is 290.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Sunwels Co and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunwels Co's current EBITDA Margin % is 40.00%, which is 311% above median its own 10-year median of 9.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunwels Co stock overvalued right now?
Based on GuruFocus' analysis, Sunwels Co (TSE:9229) is currently considered Possible Value Trap. The stock's GF Value™ is 円1,185.01, compared to a current price of 円117.00 — trading 90.1% below its estimated fair value. The current EBITDA Margin % is 40.00%, which is 311% above median its 10-year median of 9.73 and 290.6% above the Healthcare Providers & Services industry median of 10.24. Sunwels Co's overall GF Score™ is 59/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Sunwels Co (TSE:9229), the current EBITDA Margin % is 40.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sunwels Co (TSE:9229) Overvalued in 2026?
Based on GuruFocus' analysis, Sunwels Co stock appears to be undervalued.
The current stock price of 円117.00 is trading 90.1% below its estimated GF Value™ of 円1,185.01.
GuruFocus considers Sunwels Co to be Possible Value Trap.
Key valuation signals for TSE:9229:
EBITDA Margin %: 40.00% (311% above median its 10-year median of 9.73)
GF Value™: 円1,185.01 vs. price of 円117.00 (90.1% below fair value)
Industry Position: 290.6% above the Healthcare Providers & Services median (#408 of 665)
No single metric tells the full story. See the TSE:9229 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sunwels Co Ltd is engaged in the operation of nursing care business centered on PD House, fee-based homes for the elderly specialized in Parkinson's disease.
59GF Score
Get the complete analysis for TSE:9229
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9229 has been successfully added to your 
